English
简体中文
Total: £ 56.28
Published Date: 2026-03-23 | Pages: 118 | Tables: 119 | Medical Devices & Consumables
The global PET/CT Molecular Imaging System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PET/CT Molecular Imaging System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for PET/CT Molecular Imaging System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for PET/CT Molecular Imaging System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of PET/CT Molecular Imaging System include GE HealthCare, Bruker, Siemens Healthineers, Koninklijke Philips, Canon, Hitachi, Shimadzu, NeuroLogica, Neusoft Medical, United-imaging, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global PET/CT Molecular Imaging System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding PET/CT Molecular Imaging System. The PET/CT Molecular Imaging System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global PET/CT Molecular Imaging System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist PET/CT Molecular Imaging System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
GE HealthCare
Bruker
Siemens Healthineers
Koninklijke Philips
Canon
Hitachi
Shimadzu
NeuroLogica
Neusoft Medical
United-imaging
MinFound Medical Systems
Shenzhen Anke High-tech
Segment by Type
Fixed PET/CT Systems
Mobile PET/CT Systems
by Application
Hospitals
Clinics
Cancer Research Centers
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for PET/CT Molecular Imaging System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines PET/CT Molecular Imaging System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 PET/CT Molecular Imaging System Market Overview
1.1 Product Definition
1.2 PET/CT Molecular Imaging System by Type
1.2.1 Global PET/CT Molecular Imaging System Market Value by Type: 2025 vs 2032
1.2.2 Fixed PET/CT Systems
1.2.3 Mobile PET/CT Systems
1.3 PET/CT Molecular Imaging System by Application
1.3.1 Global PET/CT Molecular Imaging System Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Global PET/CT Molecular Imaging System Market Size Estimates and Forecasts
1.4.1 Global PET/CT Molecular Imaging System Revenue 2021–2032
1.4.2 Global PET/CT Molecular Imaging System Sales 2021–2032
1.4.3 Global PET/CT Molecular Imaging System Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 PET/CT Molecular Imaging System Market Competition by Manufacturers
2.1 Global PET/CT Molecular Imaging System Sales Market Share by Manufacturers (2021–2026)
2.2 Global PET/CT Molecular Imaging System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global PET/CT Molecular Imaging System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of PET/CT Molecular Imaging System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of PET/CT Molecular Imaging System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of PET/CT Molecular Imaging System, Product Types and Applications
2.7 Global Key Manufacturers of PET/CT Molecular Imaging System, Date of Entry into the Industry
2.8 Global PET/CT Molecular Imaging System Market Competitive Situation and Trends
2.8.1 Global PET/CT Molecular Imaging System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global PET/CT Molecular Imaging System Players Market Share by Revenue
2.8.3 Global PET/CT Molecular Imaging System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PET/CT Molecular Imaging System Market Scenario by Region
3.1 Global PET/CT Molecular Imaging System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global PET/CT Molecular Imaging System Sales by Region: 2021–2032
3.2.1 Global PET/CT Molecular Imaging System Sales by Region: 2021–2026
3.2.2 Global PET/CT Molecular Imaging System Sales by Region: 2027–2032
3.3 Global PET/CT Molecular Imaging System Revenue by Region: 2021–2032
3.3.1 Global PET/CT Molecular Imaging System Revenue by Region: 2021–2026
3.3.2 Global PET/CT Molecular Imaging System Revenue by Region: 2027–2032
3.4 North America PET/CT Molecular Imaging System Market Facts & Figures by Country
3.4.1 North America PET/CT Molecular Imaging System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America PET/CT Molecular Imaging System Sales by Country (2021–2032)
3.4.3 North America PET/CT Molecular Imaging System Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe PET/CT Molecular Imaging System Market Facts & Figures by Country
3.5.1 Europe PET/CT Molecular Imaging System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe PET/CT Molecular Imaging System Sales by Country (2021–2032)
3.5.3 Europe PET/CT Molecular Imaging System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PET/CT Molecular Imaging System Market Facts & Figures by Region
3.6.1 Asia Pacific PET/CT Molecular Imaging System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific PET/CT Molecular Imaging System Sales by Region (2021–2032)
3.6.3 Asia Pacific PET/CT Molecular Imaging System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PET/CT Molecular Imaging System Market Facts & Figures by Country
3.7.1 Latin America PET/CT Molecular Imaging System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America PET/CT Molecular Imaging System Sales by Country (2021–2032)
3.7.3 Latin America PET/CT Molecular Imaging System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa PET/CT Molecular Imaging System Market Facts & Figures by Country
3.8.1 Middle East and Africa PET/CT Molecular Imaging System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa PET/CT Molecular Imaging System Sales by Country (2021–2032)
3.8.3 Middle East and Africa PET/CT Molecular Imaging System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PET/CT Molecular Imaging System Sales by Type (2021–2032)
4.1.1 Global PET/CT Molecular Imaging System Sales by Type (2021–2026)
4.1.2 Global PET/CT Molecular Imaging System Sales by Type (2027–2032)
4.1.3 Global PET/CT Molecular Imaging System Sales Market Share by Type (2021–2032)
4.2 Global PET/CT Molecular Imaging System Revenue by Type (2021–2032)
4.2.1 Global PET/CT Molecular Imaging System Revenue by Type (2021–2026)
4.2.2 Global PET/CT Molecular Imaging System Revenue by Type (2027–2032)
4.2.3 Global PET/CT Molecular Imaging System Revenue Market Share by Type (2021–2032)
4.3 Global PET/CT Molecular Imaging System Price by Type (2021–2032)
5 Segment by Application
5.1 Global PET/CT Molecular Imaging System Sales by Application (2021–2032)
5.1.1 Global PET/CT Molecular Imaging System Sales by Application (2021–2026)
5.1.2 Global PET/CT Molecular Imaging System Sales by Application (2027–2032)
5.1.3 Global PET/CT Molecular Imaging System Sales Market Share by Application (2021–2032)
5.2 Global PET/CT Molecular Imaging System Revenue by Application (2021–2032)
5.2.1 Global PET/CT Molecular Imaging System Revenue by Application (2021–2026)
5.2.2 Global PET/CT Molecular Imaging System Revenue by Application (2027–2032)
5.2.3 Global PET/CT Molecular Imaging System Revenue Market Share by Application (2021–2032)
5.3 Global PET/CT Molecular Imaging System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GE HealthCare
6.1.1 GE HealthCare Company Information
6.1.2 GE HealthCare Description and Business Overview
6.1.3 GE HealthCare PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GE HealthCare PET/CT Molecular Imaging System Product Portfolio
6.1.5 GE HealthCare Recent Developments/Updates
6.2 Bruker
6.2.1 Bruker Company Information
6.2.2 Bruker Description and Business Overview
6.2.3 Bruker PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bruker PET/CT Molecular Imaging System Product Portfolio
6.2.5 Bruker Recent Developments/Updates
6.3 Siemens Healthineers
6.3.1 Siemens Healthineers Company Information
6.3.2 Siemens Healthineers Description and Business Overview
6.3.3 Siemens Healthineers PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Siemens Healthineers PET/CT Molecular Imaging System Product Portfolio
6.3.5 Siemens Healthineers Recent Developments/Updates
6.4 Koninklijke Philips
6.4.1 Koninklijke Philips Company Information
6.4.2 Koninklijke Philips Description and Business Overview
6.4.3 Koninklijke Philips PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Koninklijke Philips PET/CT Molecular Imaging System Product Portfolio
6.4.5 Koninklijke Philips Recent Developments/Updates
6.5 Canon
6.5.1 Canon Company Information
6.5.2 Canon Description and Business Overview
6.5.3 Canon PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Canon PET/CT Molecular Imaging System Product Portfolio
6.5.5 Canon Recent Developments/Updates
6.6 Hitachi
6.6.1 Hitachi Company Information
6.6.2 Hitachi Description and Business Overview
6.6.3 Hitachi PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hitachi PET/CT Molecular Imaging System Product Portfolio
6.6.5 Hitachi Recent Developments/Updates
6.7 Shimadzu
6.7.1 Shimadzu Company Information
6.7.2 Shimadzu Description and Business Overview
6.7.3 Shimadzu PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shimadzu PET/CT Molecular Imaging System Product Portfolio
6.7.5 Shimadzu Recent Developments/Updates
6.8 NeuroLogica
6.8.1 NeuroLogica Company Information
6.8.2 NeuroLogica Description and Business Overview
6.8.3 NeuroLogica PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 NeuroLogica PET/CT Molecular Imaging System Product Portfolio
6.8.5 NeuroLogica Recent Developments/Updates
6.9 Neusoft Medical
6.9.1 Neusoft Medical Company Information
6.9.2 Neusoft Medical Description and Business Overview
6.9.3 Neusoft Medical PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Neusoft Medical PET/CT Molecular Imaging System Product Portfolio
6.9.5 Neusoft Medical Recent Developments/Updates
6.10 United-imaging
6.10.1 United-imaging Company Information
6.10.2 United-imaging Description and Business Overview
6.10.3 United-imaging PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 United-imaging PET/CT Molecular Imaging System Product Portfolio
6.10.5 United-imaging Recent Developments/Updates
6.11 MinFound Medical Systems
6.11.1 MinFound Medical Systems Company Information
6.11.2 MinFound Medical Systems Description and Business Overview
6.11.3 MinFound Medical Systems PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 MinFound Medical Systems PET/CT Molecular Imaging System Product Portfolio
6.11.5 MinFound Medical Systems Recent Developments/Updates
6.12 Shenzhen Anke High-tech
6.12.1 Shenzhen Anke High-tech Company Information
6.12.2 Shenzhen Anke High-tech Description and Business Overview
6.12.3 Shenzhen Anke High-tech PET/CT Molecular Imaging System Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Shenzhen Anke High-tech PET/CT Molecular Imaging System Product Portfolio
6.12.5 Shenzhen Anke High-tech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PET/CT Molecular Imaging System Industry Chain Analysis
7.2 PET/CT Molecular Imaging System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PET/CT Molecular Imaging System Production Mode & Process Analysis
7.4 PET/CT Molecular Imaging System Sales and Marketing
7.4.1 PET/CT Molecular Imaging System Sales Channels
7.4.2 PET/CT Molecular Imaging System Distributors
7.5 PET/CT Molecular Imaging System Customer Analysis
8 PET/CT Molecular Imaging System Market Dynamics
8.1 PET/CT Molecular Imaging System Industry Trends
8.2 PET/CT Molecular Imaging System Market Drivers
8.3 PET/CT Molecular Imaging System Market Challenges
8.4 PET/CT Molecular Imaging System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global PET/CT Molecular Imaging System Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global PET/CT Molecular Imaging System Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global PET/CT Molecular Imaging System Market Competitive Situation by Manufacturers in 2025
Table 4. Global PET/CT Molecular Imaging System Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global PET/CT Molecular Imaging System Sales Market Share by Manufacturers (2021–2026)
Table 6. Global PET/CT Molecular Imaging System Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global PET/CT Molecular Imaging System Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market PET/CT Molecular Imaging System Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of PET/CT Molecular Imaging System, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of PET/CT Molecular Imaging System, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of PET/CT Molecular Imaging System, Product Types and Applications
Table 12. Global Key Manufacturers of PET/CT Molecular Imaging System, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PET/CT Molecular Imaging System Companies by Tier (Tier 1, Tier 2, Tier 3), based on PET/CT Molecular Imaging System Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PET/CT Molecular Imaging System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global PET/CT Molecular Imaging System Sales by Region (K Units), 2021–2026
Table 18. Global PET/CT Molecular Imaging System Sales Market Share by Region (2021–2026)
Table 19. Global PET/CT Molecular Imaging System Sales by Region (K Units), 2027–2032
Table 20. Global PET/CT Molecular Imaging System Sales Market Share by Region (2027–2032)
Table 21. Global PET/CT Molecular Imaging System Revenue by Region (US$ Million), 2021–2026
Table 22. Global PET/CT Molecular Imaging System Revenue Market Share by Region (2021–2026)
Table 23. Global PET/CT Molecular Imaging System Revenue by Region (US$ Million), 2027–2032
Table 24. Global PET/CT Molecular Imaging System Revenue Market Share by Region (2027–2032)
Table 25. North America PET/CT Molecular Imaging System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America PET/CT Molecular Imaging System Sales by Country (K Units), 2021–2026
Table 27. North America PET/CT Molecular Imaging System Sales by Country (K Units), 2027–2032
Table 28. North America PET/CT Molecular Imaging System Revenue by Country (US$ Million), 2021–2026
Table 29. North America PET/CT Molecular Imaging System Revenue by Country (US$ Million), 2027–2032
Table 30. Europe PET/CT Molecular Imaging System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe PET/CT Molecular Imaging System Sales by Country (K Units), 2021–2026
Table 32. Europe PET/CT Molecular Imaging System Sales by Country (K Units), 2027–2032
Table 33. Europe PET/CT Molecular Imaging System Revenue by Country (US$ Million), 2021–2026
Table 34. Europe PET/CT Molecular Imaging System Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific PET/CT Molecular Imaging System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific PET/CT Molecular Imaging System Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific PET/CT Molecular Imaging System Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific PET/CT Molecular Imaging System Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific PET/CT Molecular Imaging System Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America PET/CT Molecular Imaging System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America PET/CT Molecular Imaging System Sales by Country (K Units), 2021–2026
Table 42. Latin America PET/CT Molecular Imaging System Sales by Country (K Units), 2027–2032
Table 43. Latin America PET/CT Molecular Imaging System Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America PET/CT Molecular Imaging System Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa PET/CT Molecular Imaging System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa PET/CT Molecular Imaging System Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa PET/CT Molecular Imaging System Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa PET/CT Molecular Imaging System Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa PET/CT Molecular Imaging System Revenue by Country (US$ Million), 2027–2032
Table 50. Global PET/CT Molecular Imaging System Sales (K Units) by Type (2021–2026)
Table 51. Global PET/CT Molecular Imaging System Sales (K Units) by Type (2027–2032)
Table 52. Global PET/CT Molecular Imaging System Sales Market Share by Type (2021–2026)
Table 53. Global PET/CT Molecular Imaging System Sales Market Share by Type (2027–2032)
Table 54. Global PET/CT Molecular Imaging System Revenue (US$ Million) by Type (2021–2026)
Table 55. Global PET/CT Molecular Imaging System Revenue (US$ Million) by Type (2027–2032)
Table 56. Global PET/CT Molecular Imaging System Revenue Market Share by Type (2021–2026)
Table 57. Global PET/CT Molecular Imaging System Revenue Market Share by Type (2027–2032)
Table 58. Global PET/CT Molecular Imaging System Price (K US$/Unit) by Type (2021–2026)
Table 59. Global PET/CT Molecular Imaging System Price (K US$/Unit) by Type (2027–2032)
Table 60. Global PET/CT Molecular Imaging System Sales (K Units) by Application (2021–2026)
Table 61. Global PET/CT Molecular Imaging System Sales (K Units) by Application (2027–2032)
Table 62. Global PET/CT Molecular Imaging System Sales Market Share by Application (2021–2026)
Table 63. Global PET/CT Molecular Imaging System Sales Market Share by Application (2027–2032)
Table 64. Global PET/CT Molecular Imaging System Revenue (US$ Million) by Application (2021–2026)
Table 65. Global PET/CT Molecular Imaging System Revenue (US$ Million) by Application (2027–2032)
Table 66. Global PET/CT Molecular Imaging System Revenue Market Share by Application (2021–2026)
Table 67. Global PET/CT Molecular Imaging System Revenue Market Share by Application (2027–2032)
Table 68. Global PET/CT Molecular Imaging System Price (K US$/Unit) by Application (2021–2026)
Table 69. Global PET/CT Molecular Imaging System Price (K US$/Unit) by Application (2027–2032)
Table 70. GE HealthCare Company Information
Table 71. GE HealthCare Description and Business Overview
Table 72. GE HealthCare PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 73. GE HealthCare PET/CT Molecular Imaging System Product
Table 74. GE HealthCare Recent Developments/Updates
Table 75. Bruker Company Information
Table 76. Bruker Description and Business Overview
Table 77. Bruker PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 78. Bruker PET/CT Molecular Imaging System Product
Table 79. Bruker Recent Developments/Updates
Table 80. Siemens Healthineers Company Information
Table 81. Siemens Healthineers Description and Business Overview
Table 82. Siemens Healthineers PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 83. Siemens Healthineers PET/CT Molecular Imaging System Product
Table 84. Siemens Healthineers Recent Developments/Updates
Table 85. Koninklijke Philips Company Information
Table 86. Koninklijke Philips Description and Business Overview
Table 87. Koninklijke Philips PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 88. Koninklijke Philips PET/CT Molecular Imaging System Product
Table 89. Koninklijke Philips Recent Developments/Updates
Table 90. Canon Company Information
Table 91. Canon Description and Business Overview
Table 92. Canon PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 93. Canon PET/CT Molecular Imaging System Product
Table 94. Canon Recent Developments/Updates
Table 95. Hitachi Company Information
Table 96. Hitachi Description and Business Overview
Table 97. Hitachi PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 98. Hitachi PET/CT Molecular Imaging System Product
Table 99. Hitachi Recent Developments/Updates
Table 100. Shimadzu Company Information
Table 101. Shimadzu Description and Business Overview
Table 102. Shimadzu PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 103. Shimadzu PET/CT Molecular Imaging System Product
Table 104. Shimadzu Recent Developments/Updates
Table 105. NeuroLogica Company Information
Table 106. NeuroLogica Description and Business Overview
Table 107. NeuroLogica PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 108. NeuroLogica PET/CT Molecular Imaging System Product
Table 109. NeuroLogica Recent Developments/Updates
Table 110. Neusoft Medical Company Information
Table 111. Neusoft Medical Description and Business Overview
Table 112. Neusoft Medical PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 113. Neusoft Medical PET/CT Molecular Imaging System Product
Table 114. Neusoft Medical Recent Developments/Updates
Table 115. United-imaging Company Information
Table 116. United-imaging Description and Business Overview
Table 117. United-imaging PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 118. United-imaging PET/CT Molecular Imaging System Product
Table 119. United-imaging Recent Developments/Updates
Table 120. MinFound Medical Systems Company Information
Table 121. MinFound Medical Systems Description and Business Overview
Table 122. MinFound Medical Systems PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 123. MinFound Medical Systems PET/CT Molecular Imaging System Product
Table 124. MinFound Medical Systems Recent Developments/Updates
Table 125. Shenzhen Anke High-tech Company Information
Table 126. Shenzhen Anke High-tech Description and Business Overview
Table 127. Shenzhen Anke High-tech PET/CT Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 128. Shenzhen Anke High-tech PET/CT Molecular Imaging System Product
Table 129. Shenzhen Anke High-tech Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. PET/CT Molecular Imaging System Distributors List
Table 133. PET/CT Molecular Imaging System Customers List
Table 134. PET/CT Molecular Imaging System Market Trends
Table 135. PET/CT Molecular Imaging System Market Drivers
Table 136. PET/CT Molecular Imaging System Market Challenges
Table 137. PET/CT Molecular Imaging System Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of PET/CT Molecular Imaging System
Figure 2. Global PET/CT Molecular Imaging System Market Value by Type (US$ Million), 2021–2032
Figure 3. Global PET/CT Molecular Imaging System Market Share by Type: 2025 & 2032
Figure 4. Fixed PET/CT Systems Product Picture
Figure 5. Mobile PET/CT Systems Product Picture
Figure 6. Global PET/CT Molecular Imaging System Market Value by Application (US$ Million), 2021–2032
Figure 7. Global PET/CT Molecular Imaging System Market Share by Application: 2025 & 2032
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Cancer Research Centers
Figure 11. Global PET/CT Molecular Imaging System Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global PET/CT Molecular Imaging System Market Size (US$ Million), 2021–2032
Figure 13. Global PET/CT Molecular Imaging System Sales (K Units), 2021–2032
Figure 14. Global PET/CT Molecular Imaging System Average Price (K US$/Unit), 2021–2032
Figure 15. PET/CT Molecular Imaging System Report Years Considered
Figure 16. PET/CT Molecular Imaging System Sales Share by Manufacturers in 2025
Figure 17. Global PET/CT Molecular Imaging System Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global PET/CT Molecular Imaging System Players: Market Share by Revenue in PET/CT Molecular Imaging System in 2025
Figure 19. PET/CT Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global PET/CT Molecular Imaging System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America PET/CT Molecular Imaging System Sales Market Share by Country (2021–2032)
Figure 22. North America PET/CT Molecular Imaging System Revenue Market Share by Country (2021–2032)
Figure 23. United States PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe PET/CT Molecular Imaging System Sales Market Share by Country (2021–2032)
Figure 26. Europe PET/CT Molecular Imaging System Revenue Market Share by Country (2021–2032)
Figure 27. Germany PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific PET/CT Molecular Imaging System Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific PET/CT Molecular Imaging System Revenue Market Share by Region (2021–2032)
Figure 34. China PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America PET/CT Molecular Imaging System Sales Market Share by Country (2021–2032)
Figure 42. Latin America PET/CT Molecular Imaging System Revenue Market Share by Country (2021–2032)
Figure 43. Mexico PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa PET/CT Molecular Imaging System Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa PET/CT Molecular Imaging System Revenue Market Share by Country (2021–2032)
Figure 49. Turkey PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE PET/CT Molecular Imaging System Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of PET/CT Molecular Imaging System by Type (2021–2032)
Figure 53. Global Revenue Market Share of PET/CT Molecular Imaging System by Type (2021–2032)
Figure 54. Global PET/CT Molecular Imaging System Price (K US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of PET/CT Molecular Imaging System by Application (2021–2032)
Figure 56. Global Revenue Market Share of PET/CT Molecular Imaging System by Application (2021–2032)
Figure 57. Global PET/CT Molecular Imaging System Price (K US$/Unit) by Application (2021–2032)
Figure 58. PET/CT Molecular Imaging System Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
